|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/435 |
| (11) | Patento numeris | 3129395 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15713529.4 |
| Europos patento paraiškos padavimo data | 2015-04-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-02-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-12-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2015/057416 |
| Data | 2015-04-02 |
| (87) | Numeris | WO 2015/155139 |
| Data | 2015-10-15 |
| (30) | Numeris | Data | Šalis |
| 14305501 | 2014-04-07 | EP |
| (72) |
BOSSART, Martin, DE
ELVERT, Ralf, DE
EVERS, Andreas, DE
HAACK, Torsten, DE
STENGELIN, Siegfried, DE
WAGNER, Michael, DE
|
| (73) |
SANOFI,
54, rue La Boétie, 75008 Paris,
FR
|
| (54) | EXENDIN-4 DERIVATIVES AS PEPTIDIC DUAL GLP-1 / GLUCAGON RECEPTOR AGONISTS |
| EXENDIN-4 DERIVATIVES AS PEPTIDIC DUAL GLP-1 / GLUCAGON RECEPTOR AGONISTS |